OMEGA-3 SYNTHESIS SUPPORT Expanding our Understanding
How Emerging Science is reshaping What we Know about ALA, EPA, and DHA For decades, the omega-3 conversation has been shaped by a straightforward narrative: Marine sources like EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), are the most relevant forms, with plant-based omega-3s playing a limited role. While plant foods provide plenty of ALA (alpha-linolenic acid) that the body can convert into DHA and EPA, the conversion rates are so low as to be of marginal significance.
What Is ALA and Why does it Matter? ALA is the omega-3 fatty acid found in plant-based foods, including chia seeds, as well as walnuts, flaxseeds, and hemp seeds. It is classified as the only essential omega-3 fatty acid, meaning the body cannot synthesize it independently and must obtain it through diet or
That narrative is now being meaningfully challenged. Emerging research made possible by significant advances in analytical technology is revealing that ALA plays
supplementation. Once absorbed, ALA can be converted through a series of enzymatic steps into the longer-chain omega-3s: first EPA,
a more active and purposeful role in the body’s omega-3 system than previously understood. It’s a major shift, and one that has real implications for how we evaluate ingredients, design products, and communicate with consumers. Here’s a closer look at the science behind these changes, the tools that are making it possible, and what it may mean for the world of omega-3s going forward.
and subsequently DHA. ALA, EPA, and DHA are associated with cardiovascular health, cognitive suppot, inflammatory response, membrane structure and signaling, and a range of other physiological processes. The traditional limitation assigned to ALA has been its conversion efficiency. Studies using conventional methods reported conversion rates of less than 1% from ALA to DHA, leading many researchers and practitioners to treat ALA as metabolically inconsequential — a secondary omega-3 source appropriate mainly for those unable or unwilling to consume marine-derived options.
THE BASICS OF PUFAS METABOLIC PATHWAY ß-Oxidation
Omega-3
Omega-6
Storage
Alpha-linolenic Acid (ALA)
Linolenic Acid (LA)
Cell membranes
Desaturases Elongases Desaturases Elongases
EPA
AA Cyclooxygenases (COX) Lipoxygenases
DHA D-Resolvins Maresins
Desaturases Elongases
Cyclooxygenases (COX) Lipoxygenases Prostaglandins
E-Resolvins
Protectins PRO-RESOLUTIVE
OMEGA-3 SYNTHESIS SUPPORT: EXPANDING OUR UNDERSTANDING
Thromboxanes Leukotrienes PRO-INFLAMMATORY
Why that Framework may be Incomplete The core limitation of traditional conversion studies is methodological, since they measured omega-3 metabolism as though it were a static system. Researchers would assess DHA levels before and after ALA supplementation, and when blood DHA failed to increase, the conclusion was predictable: ALA had poor conversion. The problem is that this approach treats the body like a closed container, when in reality it functions as a continuously regulated system. Measuring DHA at a single point in time captures a snapshot, not the full metabolic picture. Consider a reservoir that maintains a constant water level. If you add water and the level holds steady, the naive interpretation is that your input isn’t getting through. A more accurate explanation may be that water is flowing in and out at matching rates, and the system is working precisely as intended. That same principle is now thought to apply to DHA metabolism in the body.
The omega-3 system is not a simple input-output pathway. It is a tightly balanced metabolic system.
The Traditional Assumption: ALA converts too inefficiently to DHA to contribute meaningfully to omega-3 status.
HOW EMERGING SCIENCE IS RESHAPING WHAT WE KNOW ABOUT ALA, EPA, AND DHA
3
The Technology Driving the New Understanding: CSIA
Richard Bazinet, Ph.D., and colleagues at the University of Toronto have been at the forefront of applying CSIA to omega-3 research, introducing the concepts of turnover, flux, and half-life to reframe how conversion
The analytical method responsible for reshaping omega-3
and utilization are interpreted. With CSIA, researchers
science is Compound-Specific Isotope Analysis (CSIA).
can now:
This high-precision technique, typically performed using gas chromatography-combustion isotope ratio mass
•
spectrometry (GC-cIRMS), analyzes naturally occurring
Determine whether circulating DHA originated from dietary sources or was synthesized internally from
carbon isotope patterns embedded in individual fatty
precursors like ALA
acid molecules.
•
In practical terms, CSIA functions like a molecular
Quantify the activity of the conversion pathway even when blood DHA levels remain unchanged
tracking system. Because carbon atoms from different
•
dietary sources carry slightly distinct isotopic signatures,
Differentiate between DHA that is actively being utilized and DHA that is in passive circulation
researchers can follow individual fatty acids through the
•
body — tracing their path from dietary intake, through
Examine metabolic behavior across multiple
enzymatic conversion, into tissue incorporation and
tissue compartments, rather than being limited to
eventual utilization. This level of resolution was simply not
blood measurements
available with earlier methods like blood tests.
OMEGA-3 INDEX: THE TRADITIONAL WAY
Static Measurement "A Picture" Total Omega-3s
= Omega-3s Index %
Total Fatty Acids
It measures the amount of EPA-DHA in the red blood cell membrane expressed as the percent of total fatty acids present only at that time.
Omega-3s
OMEGA-3 CSIA: THE DISRUPTIVE WAY
Dynamic Measurement "A Tracking" It tracks the movements of each fatty acid in the body by measuring the C-13 isotope at different stages, creating a dynamic model that shows how much was converted, used in each tissue, stored, and its precursor. 1: Diet 2: Conversion 3: Use 4: Storage
ALA
DHA
OMEGA-3 SYNTHESIS SUPPORT: EXPANDING OUR UNDERSTANDING
EPA
The New Perspective: ALA may be converting to DHA at a biologically meaningful and regulated rate — one that older methodologies were structurally unable to detect.
Turnover: The Concept that Reframes Conversion These compounds actively support the resolution of
Traditional studies measured DHA levels. They did not measure DHA turnover. Among the most consequential ideas to emerge from this research is the concept of turnover, or the continuous cycle through which DHA is both synthesized and consumed within the body.
inflammation, promote tissue recovery, and contribute to the maintenance of physiological homeostasis. This distinction matters significantly for how we interpret supplementation studies. For decades, researchers observed stable DHA levels following ALA supplementation and concluded that conversion is negligible. The CSIA-based evidence suggests a different interpretation may often be more accurate. Conversion
At any given moment, the body is simultaneously
is occurring actively, but newly synthesized DHA is being
producing DHA (through endogenous conversion from ALA
utilized as rapidly as it is produced, maintaining a stable
and other precursors) and consuming DHA (deploying it
balance rather than accumulating visibly in circulation.
in the brain, retina, heart, and other tissues). When these two processes occur at roughly equivalent rates, blood DHA levels remain stable — not because conversion is absent, but because the system is in equilibrium. A key aspect of omega-3 metabolism involves the production lipid mediators that support immune balance and inflammation resolution. While arachidonic acid (AA)
Put plainly: stable DHA levels may not indicate a system that is failing to convert. They may indicate a system that is functioning as designed.
gives rise to pro-inflammatory mediators, EPA and DHA are precursors to specialized pro-resolving mediators (SPMs), including resolvins, maresins, and protectins.
HOW EMERGING SCIENCE IS RESHAPING WHAT WE KNOW ABOUT ALA, EPA, AND DHA
5
Half-Life, Tissue Dynamics, and Metabolic Demand
Revisiting the Retroconversion Hypothesis
A second concept that strengthens this reframing involves
One additional area where emerging science is revising
half-life, or the time it takes for a substance to be reduced
long-held assumptions involves retroconversion — the
by half in the body. In omega-3 metabolism, half-life
proposed conversion of DHA back into EPA, widely cited
varies considerably by tissue. DHA in blood and liver
as an explanation for why EPA levels rise in individuals
turns over relatively quickly, while DHA in the brain is
supplementing with DHA.
retained substantially longer, with estimates suggesting a half-life of approximately 900 days (nearly 2.5 years) in neural tissue.
Recent CSIA-based investigations have largely challenged this interpretation. Current evidence suggests that rising EPA following DHA supplementation is more
This differential is significant because the majority of
likely explained by a regulatory mechanism. When DHA
human omega-3 research has relied on blood-based
intake exceeds physiological requirements, the enzymes
measurements. These compartments reflect short-term
responsible for converting EPA to DHA are downregulated,
metabolic dynamics but do not necessarily capture what is
causing EPA to accumulate. This reinforces the view that
happening in slower-cycling, more tightly balanced tissues
the omega-3 system is not a linear input-output pathway
like the brain. Emerging evidence suggests the body
but a tightly regulated homeostatic axis, one in which
operates a continuous, regulated pipeline in which ALA is
maintaining adequate ALA as a precursor remains relevant
converted in the liver and the resulting DHA is distributed
even when preformed DHA is also being supplemented.
to key tissues over time. Short-term blood measurements cannot fully capture this process. Taken together, turnover and half-life point toward a broader principle. The body actively regulates DHA availability in response to physiological demand rather than managing it passively. This shifts the central question of omega-3 adequacy from “How much DHA is present?” to “Is DHA being maintained effectively to meet functional requirements?” It’s a different, and more clinically relevant, standard.
DID YOU KNOW? The adult human brain is estimated to consume approximately 4 mg of DHA per day.
OMEGA-3 SYNTHESIS SUPPORT: EXPANDING OUR UNDERSTANDING
Can ALA Support the Brain’s Omega-3 Needs? Based on kinetic modeling using CSIA methodology,
to improved global cognitive performance, ALA showed
researchers estimate that the adult human brain
a distinct and complementary association, suggesting
consumes approximately 4 mg of DHA per day under
independent benefits.
normal metabolic conditions. Studies suggest that an ALA intake of ~1,200 mg/day — achievable from about one teaspoon of chia oil (3 g ALA/tsp) — may support endogenous production of 2.4–3.6 mg of DHA per day, potentially reaching 5–8 mg when intermediate pathway flux is considered, with emerging evidence suggesting higher conversion efficiency than previously assumed. This range may be sufficient to meet the brain’s daily DHA maintenance requirement.
A 2026 analysis of the UK Biobank (over 217,000 participants; 8.3-year follow-up) examined plasma omega-3 levels and early-onset dementia risk. Higher omega-3 status was associated with a 36% lower risk, with a slightly stronger inverse association for non-DHA omega-3s (including ALA) than for DHA alone, suggesting independent contributions to brain health. These findings are observational and therefore cannot establish causation.ALA conversion efficiency also varies
Recommended Dietary Intake
by genetics, sex, age, and diet. Nevertheless, the evidence
The recommended dietary intake (RDI) for ALA, as defined
system with potential relevance for brain health.
supports ALA as an active contributor to the omega-3
by the Institute of Medicine (IOM), is 1.6 g/day for men and 1.1 g/day for women. EPA and DHA are not assigned equivalent RDI values within this framework, highlighting ALA’s status as an essential omega-3 fatty acid. From a metabolic perspective, approximately 67% of ALA in the brain is directed toward beta-oxidation, where fatty acids are broken down for energy. This has historically been cited as evidence of limited conversion. However, beta-oxidation is not unique to ALA: DHA is oxidized at similar rates (~65%). Emerging evidence indicates that the remaining fraction is sufficient to meet physiological requirements, particularly in the brain.
New Evidence: ALA and Long-Term Brain Health A growing body of observational evidence links ALA status with cognitive outcomes over time. A 2025 longitudinal study from the ALFA cohort (The Journal of Nutrition) followed 323 middle-aged adults at elevated risk of Alzheimer’s disease for 3 years. Higher red blood cell ALA levels were significantly associated with improved visual processing, even after adjustment. While DHA was linked
CAN ALA SUPPORT THE BRAIN’S OMEGA-3 NEEDS?
7
The Role of Chia Oil in the New Omega-3 Framework As the science around ALA evolves, so too does the opportunity for ingredients that deliver high-quality plant-based omega-3 precursors in practical, scalable forms. Chia oil is one of the most compelling examples of this shift, and its profile aligns directly with the emerging narrative described in this paper.
A High-Concentration ALA source Chia oil (Salvia hispanica L.) is among the richest plantderived sources of ALA available, with ALA content
Formulation and sustainability advantages Beyond its nutritional profile, chia oil offers meaningful practical advantages for product developers including relatively low input requirements and compatibility with regenerative and climate-resilient agricultural systems. Relative to other high-ALA oils such as flaxseed oil, chia oil demonstrates favorable oxidative stability — a critical factor for shelf life, sensory quality, and consumer compliance. Its mild flavor profile also avoids the sensory challenges that have historically limited adherence with
typically exceeding 60% of total fatty acids. Clinical
marine omega-3 products.
research has also begun to explore its practical utility.
On the sustainability side, chia is an annual crop well-
Studies indicate that chia oil supplementation during pregnancy and nursing can influence DHA composition in breast milk, supporting the view that ALA from chia is bioavailable and metabolically active within the omega-3 pathway, not simply stored.
suited to arid and semi-arid growing conditions, and is increasingly cultivated at scale in Latin America. As global demand for omega-3s grows and marine supply chains face growing environmental pressure, plant-based sources like chia oil offer an extensible, resilient complement.
Strategic Precursor XIA OIL BROCHURE Scan the QR code to access Xia Oil: A New Sustainable Natural Source of Omega-3.
Within the reframed omega-3 narrative, chia oil can be viewed not simply as a plant-based alternative to fish oil, but as a strategic precursor that actively supports the body’s endogenous omega-3 maintenance system. For nutrition innovation teams, this positions high-quality chia oil as a relevant ingredient across everyday functional nutrition, plant-forward supplement formulations, and products designed for populations with low or no marine food consumption.
The most accurate framework is not ‘plants vs. marine,’ but ‘plants plus marine.’
OMEGA-3 SYNTHESIS SUPPORT: EXPANDING OUR UNDERSTANDING
Implications for Nutrition Innovation direct relevance for product development, regulatory
The Bottom Line
affairs, clinical nutrition, and consumer communication.
The emerging science of omega-3 metabolism
Plant-based omega-3 precursors should no longer be
presents a more nuanced and ultimately
The scientific developments described in this paper have
assessed solely through the lens of how much they raise blood DHA. ALA functions as an active participant in a managed omega-3 maintenance system, and communicating that it “converts poorly to DHA” alone reflects an incomplete model of omega-3 physiology. A more accurate framing acknowledges that the body
more complete picture than the traditional framework allowed. The body does not passively accumulate or fail to convert ALA. Rather, it actively manages a dynamic, selfmanaged omega-3 system that responds to physiological demand, tissue-specific
dynamically regulates DHA synthesis and utilization in
requirements, and dietary input over time.
response to physiological demand. What’s more, that
CSIA technology has made it possible to
ALA contributes to that system in ways that conventional measurement approaches were not equipped to detect. The most scientifically aligned positioning is not “plants vs. marine” but “plants plus marine when needed.” ALA supports endogenous synthesis and day-to-day omega-3 maintenance, while preformed EPA and DHA address targeted clinical contexts and elevated physiological demand. This framework also creates space for more
observe this system in motion for the first time, and what researchers are finding is that ALA may contribute far more than conventional measurement approaches suggested. Growing observational evidence further indicates that ALA status is independently associated with certain cognitive outcomes over time, adding a new
differentiated product innovation: broad, everyday
dimension to the case for its importance.
omega-3 nutrition where plant-based ALA sources are
This does not displace the clinical importance
well positioned, alongside targeted interventions where preformed DHA remains the primary focus.
Where Preformed DHA Remains Essential This framework does not diminish the clinical importance of preformed DHA. In specific contexts, like pregnancy
of preformed EPA and DHA. It does, however, support a more complete and scientifically grounded omega-3 framework — one in which plant and marine sources are recognized as complementary contributors to a shared physiological system, and in which high-quality ALA ingredients like chia oil have a well-defined and meaningful role.
and early childhood development, premature birth, and recovery from traumatic brain injury, metabolic demand for DHA exceeds what conversion from precursors can reliably supply. ALA and preformed DHA serve complementary roles: ALA supports baseline maintenance and endogenous supply, while preformed DHA addresses conditions of elevated or acute physiological demand.
LINKEDIN GROUP Scan the QR code to join “New Science on Essential Precursors to EPA & DHA.”
THE ROLE OF CHIA OIL IN THE NEW OMEGA-3 FRAMEWORK
9
References 1.
Abdelhamid, A. S., Brown, T. J., Brainard, J. S., Biswas, P., Thorpe, G. C., Moore, H. J., Deane, K. H. O., Summerbell, C. D., Worthington, H. V., Song, F., & Hooper, L. (2020). Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews, 2020(3), CD003177. https://doi. org/10.1002/14651858.CD003177.pub5
2.
Blasbalg, T. L., Hibbeln, J. R., Ramsden, C. E., Majchrzak, S. F., & Rawlings, R. R. (2011). Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. The American Journal of Clinical Nutrition, 93(5), 950–962. https://doi.org/10.3945/ajcn.110.006643
16.
Goyens, P. L. L., Spilker, M. E., Zock, P. L., Katan, M. B., & Mensink, R. P. (2006). Conversion of α-linolenic acid in humans is influenced by absolute amounts of α-linolenic acid and linoleic acid in the diet. The American Journal of Clinical Nutrition, 84(1), 44–53. https://doi.org/10.1093/ajcn/84.1.44
17.
Harris, W. S., & von Schacky, C. (2004). The omega-3 index: A new risk factor for death from coronary heart disease? Preventive Medicine, 39(1), 212–220. https:// doi.org/10.1016/j.ypmed.2004.02.030
18.
Innis, S. M. (2007). Dietary (n-3) fatty acids and brain development. The Journal of Nutrition, 137(4), 855–859. https://doi.org/10.1093/jn/137.4.855
19.
Kris-Etherton, P. M., Harris, W. S., & Appel, L. J. (2002). Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation, 106(21), 2747–2757. https://doi.org/10.1161/01.CIR.0000038493.65177.94
20.
Lacombe, R. J., Chouinard-Watkins, R., Bazinet, R. P., & McNamara, R. K. (2020). Brain docosahexaenoic acid turnover and half-life in adult mice determined using natural abundance carbon isotope analysis. Journal of Lipid Research, 61(4), 573–581. https://doi.org/10.1194/jlr.RA119000485
21.
Lauritzen, L., Hansen, H. S., Jørgensen, M. H., & Michaelsen, K. F. (2001). The essentiality of long-chain n-3 fatty acids in relation to brain and retinal development. Progress in Lipid Research, 40(1–2), 1–94. https://doi.org/10.1016/S01637827(00)00017-5
3.
Brenna, J. T., Salem, N., Jr., Sinclair, A. J., & Cunnane, S. C. (2009). α-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins, Leukotrienes and Essential Fatty Acids, 80(2–3), 85–91. https://doi.org/10.1016/j.plefa.2009.01.004
4.
Burdge, G. C. (2006). Metabolism of α-linolenic acid in humans. Prostaglandins, Leukotrienes and Essential Fatty Acids, 75(3), 161–168. https://doi.org/10.1016/j. plefa.2006.05.013
5.
Burdge, G. C., & Calder, P. C. (2005). Conversion of α-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reproduction, Nutrition, Development, 45(5), 581–597. https://doi.org/10.1051/rnd:2005047
6.
Calder, P. C. (2014). Very long chain omega-3 (n-3) fatty acids and human health. European Journal of Lipid Science and Technology, 116(10), 1280–1300. https://doi. org/10.1002/ejlt.201400025
22.
Calder, P. C. (2017). Omega-3 fatty acids and inflammatory processes: From molecules to man. Biochemical Society Transactions, 45(5), 1105–1115. https://doi. org/10.1042/BST20160474
Leonard, A. E., Pereira, S. L., Sprecher, H., & Huang, Y.-S. (2004). Elongation of longchain fatty acids. Progress in Lipid Research, 43(1), 36–54. https://doi.org/10.1016/ S0163-7827(03)00040-7
23.
Calder, P. C., & Yaqoob, P. (2009). Understanding omega-3 polyunsaturated fatty acids. Postgraduate Medicine, 121(6), 148–157. https://doi.org/10.3810/ pgm.2009.11.2083
Lin, Y.-H., Hibbeln, J. R., Domenichiello, A. F., Ramsden, C. E., Salem, N., Chen, C.-T., & Bazinet, R. P. (2018). Human synthesis-secretion rates of DHA and EPA from α-linolenic acid. Lipids, 53(6), 547–558. https://doi.org/10.1002/lipd.12059
24.
Masson, G., Bernoud-Hubac, N., Lagarde, M., & Véricel, E. (2017). Retroconversion of docosahexaenoic acid is limited and does not account for increases in eicosapentaenoic acid following DHA supplementation. Prostaglandins, Leukotrienes and Essential Fatty Acids, 126, 17–23. https://doi.org/10.1016/j.plefa.2017.08.006
7.
8.
9.
Coletta, J. M., Bell, S. J., & Roman, A. S. (2010). Omega-3 fatty acids and pregnancy. Reviews in Obstetrics & Gynecology, 3(4), 163–171.
10.
Djuricic, I., & Calder, P. C. (2021). Beneficial outcomes of omega-6 and omega-3 polyunsaturated fatty acids on human health: An update for 2021. Nutrients, 13(7), 2421. https://doi.org/10.3390/nu13072421
25.
McNamara, R. K., & Carlson, S. E. (2006). Role of omega-3 fatty acids in brain development and function. Prostaglandins, Leukotrienes and Essential Fatty Acids, 75(4–5), 329–349. https://doi.org/10.1016/j.plefa.2006.07.010
11.
Domenichiello, A. F., Kitson, A. P., Metherel, A. H., Chen, C.-T., Hopperton, K. E., & Bazinet, R. P. (2014). Whole-body synthesis-secretion of docosahexaenoic acid from α-linolenic acid is regulated by dietary DHA. Journal of Lipid Research, 55(10), 2069–2080. https://doi.org/10.1194/jlr.M050013
26.
Metherel, A. H., & Bazinet, R. P. (2019). Updates on the use of stable isotopes to study omega-3 fatty acid metabolism in humans. Prostaglandins, Leukotrienes and Essential Fatty Acids, 142, 1–7. https://doi.org/10.1016/j.plefa.2019.01.003
12.
Dyall, S. C. (2015). Long-chain omega-3 fatty acids and the brain. Frontiers in Aging Neuroscience, 7, 52. https://doi.org/10.3389/fnagi.2015.00052
27.
13.
EFSA Panel on Dietetic Products, Nutrition and Allergies. (2010). Scientific opinion on dietary reference values for fats. EFSA Journal, 8(3), 1461. https://doi.org/10.2903/j. efsa.2010.1461
Metherel, A. H., Irfan, M., Klingel, S. L., Mutch, D. M., & Bazinet, R. P. (2019). Compound-specific isotope analysis reveals no retroconversion of DHA to EPA but substantial conversion of EPA to DHA following supplementation. The American Journal of Clinical Nutrition, 110(4), 823–831. https://doi.org/10.1093/ajcn/nqz097
28.
14.
FAO/WHO. (2010). Fats and fatty acids in human nutrition (FAO Food and Nutrition Paper No. 91). FAO.
Mozaffarian, D., & Wu, J. H. Y. (2011). Omega-3 fatty acids and cardiovascular disease: Effects on risk factors, molecular pathways, and clinical events. Journal of the American College of Cardiology, 58(20), 2047–2067. https://doi.org/10.1016/j. jacc.2011.06.063
15.
Flock, M. R., Skulas-Ray, A. C., Harris, W. S., Etherton, T. D., Fleming, J. A., & KrisEtherton, P. M. (2013). Determinants of erythrocyte omega-3 fatty acid content in response to fish oil supplementation. Journal of Lipid Research, 54(10), 2859–2868. https://doi.org/10.1194/jlr.M039479
29.
Naghshi, S., Sadeghi, O., Willett, W. C., & Esmaillzadeh, A. (2021). Dietary intake and biomarkers of alpha-linolenic acid and risk of all-cause, cardiovascular, and cancer mortality: Systematic review and dose-response meta-analysis of cohort studies. BMJ, 375, n2213. https://doi.org/10.1136/bmj.n2213
OMEGA-3 SYNTHESIS SUPPORT: EXPANDING OUR UNDERSTANDING
30.
Rapoport, S. I. (2008). Brain arachidonic and docosahexaenoic acid cascades are selectively altered by diet and disease. Prostaglandins, Leukotrienes and Essential Fatty Acids, 79(3–5), 153–156. https://doi.org/10.1016/j.plefa.2008.09.014
31.
Rapoport, S. I., Rao, J. S., & Igarashi, M. (2007). Brain metabolism of nutritionally essential polyunsaturated fatty acids depends on both diet and liver synthesis. Prostaglandins, Leukotrienes and Essential Fatty Acids, 77(5–6), 251–261. https:// doi.org/10.1016/j.plefa.2007.10.020
32.
Sala-Vila, A., Fleming, J., Kris-Etherton, P., & Ros, E. (2022). Impact of α-linolenic acid, the vegetable ω-3 fatty acid, on cardiovascular disease and cognition. Advances in Nutrition, 13(5), 1584–1602. https://doi.org/10.1093/advances/nmac016
33.
Sprecher, H. (2011). Metabolism of highly unsaturated n-3 and n-6 fatty acids. Biochimica et Biophysica Acta – Molecular and Cell Biology of Lipids, 1811(6), 343–348. https://doi.org/10.1016/j.bbalip.2010.12.006
34.
Sprague, M., Dick, J. R., & Tocher, D. R. (2016). Impact of sustainable feeds on omega-3 long-chain fatty acid levels in farmed Atlantic salmon, 2006–2015. Scientific Reports, 6, 21892. https://doi.org/10.1038/srep21892
35.
Tocher, D. R. (2015). Omega-3 long-chain polyunsaturated fatty acids and aquaculture in perspective. Aquaculture, 449, 94–107. https://doi.org/10.1016/j. aquaculture.2015.01.010
36.
Valenzuela, R., Bascuñán, K., Chamorro, R., Barrera, C., Sandoval, J., Puigrredon, C., Parraguez, G., Orellana, P., Gonzalez, V., & Valenzuela, A. (2015). Modification of docosahexaenoic acid composition of milk from nursing women who received alpha-linolenic acid from chia oil during gestation and nursing. Nutrients, 7(8), 6405–6424. https://doi.org/10.3390/nu7085289
37.
Walsh, T. A., Bevan, S. A., Gachotte, D. J., Larsen, C. M., Moskal, W. A., Owens Merlo, P. A., Sidorenko, L. V., Hampton, R. E., Stoltz, V., Pareddy, D., Anthony, G. I., Bhaskar, P. B., Marri, P. R., Clark, L. M., Chen, W., Adu-Peasah, P. S., Wensing, S. T., Zirkle, R., & Metz, J. G. (2016). Canola engineered with a microalgal polyketide synthase-like system produces oil enriched in docosahexaenoic acid. Nature Biotechnology, 34(8), 881–887. https://doi.org/10.1038/nbt.3585
38.
West, A. L., Miles, E. A., Lillycrop, K. A., Napier, J. A., Calder, P. C., & Burdge, G. C. (2021). Genetically modified plants are an alternative to oily fish for providing n-3 polyunsaturated fatty acids in the human diet: A summary of the findings of a Biotechnology and Biological Sciences Research Council funded project. Nutrition Bulletin, 46(1), 60–68. https://doi.org/10.1111/nbu.12478
REFERENCES
11
SCIENTIFIC REFERENCES Scan the QR code to access the brochure with the reference list.
Luis Pasteur 5850, Of. 403, Vitacura, Santiago - Chile |
Tel: + (56 2) 2437 5820 | info@benexia.com |
www.benexia.com